(Press-News.org) Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
The authors performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identified by whole exome sequencing and mass spectrometry-based validation across 430 lung squamous tumors.
They report a mean of 11.6 mutations/Mb with a characteristic smoking signature along with mutations in TP53, CDKN2A, NFE2L2, FAT1, KMT2C, LRP1B, FGFR1, PTEN and PREX2 among lung squamous cell carcinoma patients of Indian descent.
In overall, the data suggests 13.5% lung squamous patients harboring druggable mutations have lower median overall survival, and 19% patients with a mutation in at least one gene, known to be associated with cancer, result in significantly shorter median overall survival compared to those without mutations.
They present the first comprehensive landscape of genetic alterations underlying Indian lung squamous cell carcinoma patients and identify EGFR, PIK3CA, KRAS and FGFR1 as potentially important therapeutic and prognostic target.
Dr. Amit Dutt and Dr. Kumar Prabhash said, "Lung cancer is the leading cause of cancer-related deaths across the globe with more than 1.7 million deaths annually."
"Lung cancer is the leading cause of cancer-related deaths across the globe with more than 1.7 million deaths annually."
Non-small cell lung cancer, a more common type of lung cancer, accounts for 85% of all lung cancers comprising two major histological subtypes, adenocarcinoma and squamous cell carcinoma.
The adenocarcinoma of the lung arises mostly in patients with no previous significant tobacco exposure, while the squamous subtype is found almost exclusively in former or current smokers with relatively higher overall mutational load.
However, no approved targeted therapy regimens are available for lung squamous patients in spite of distinct genetic alterations identified in the tumor type, including alterations in TP53, PIK3CA, CDKN2A, MLL2, PTEN, KEAP1, NFE2L2,DDR2, FGFR1, PDGFRA, SOX2, and CCND1.
Moreover, most of the reported studies describe Caucasian, Chinese, Korean and Japanese population, with sparse information on the molecular profile of lung squamous patients of Indian origin that accounts for about 30% of Indian lung cancer disease.
In this study, the authors sought to describe the first genetic landscape of alterations underlying 430 Indian lung squamous genomes and uncover the prevalence of known targetable somatic alterations using next generation sequencing followed by validation using mass spectrometry.
The Dutt/Prabhash Research Team concluded in their Oncotarget Research Output, "we present a striking variation of genetic heterogeneity among lung squamous cell carcinoma patients of Indian descent. The findings from this study extend the scope of the ongoing umbrella clinical trials such as the Lung-MAP master protocol that aims to evaluate multiple targeted therapeutic strategies in lung squamous cell carcinoma patients and the AACR Project GENIE database collaborative project [29, 39]. A systematic exploration of these target genes in lung squamous cell carcinoma patients and variability across ethnicity could further extend our insights into the etiology of lung squamous cancer."
INFORMATION:
DOI - https://doi.org/10.18632/oncotarget.27905
Full text - https://www.oncotarget.com/article/27905/text/
Correspondence to - Amit Dutt - adutt@actrec.gov.in and Kumar Prabhash - kprabhash1@gmail.com
Keywords -
lung squamous carcinoma,
genetic alterations,
druggable mutations,
whole exome sequencing,
mass spectrometry
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105
When the COVID-19 pandemic arrived in North America in March 2020, health care facilities stopped providing all but "essential" care, to reduce infection risks and preserve protective gear known as PPE.
That included changes at many centers that provide ECT (electroconvulsive therapy) for severe depression and other conditions, a new survey shows.
Because ECT involves anesthesia, so that patients are unconscious when carefully controlled pulses of electricity are delivered to key areas of the brain, it is considered an 'aerosol generating' procedure. That means it poses special risks when a respiratory ...
* ICFO researchers report in Nature on having achieved, for the first time, entanglement of two multimode quantum memories located in different labs separated by 10 meters, and heralded by a photon at the telecommunication wavelength.
* The scientists implemented a technique that allowed them to reach a record in the entanglement rate in a system that could be integrated into the fibre communication network, paving the way to operation over long distances.
* The results are considered a landmark for quantum communications and a major step forward in the development of quantum repeaters for the future quantum internet.
During the 90s, engineers made major advances in the telecom arena spreading out the network to distances beyond the ...
TROY, N.Y. -- Oxygen levels in the world's temperate freshwater lakes are declining rapidly -- faster than in the oceans -- a trend driven largely by climate change that threatens freshwater biodiversity and drinking water quality.
Research published today in Nature found that oxygen levels in surveyed lakes across the temperate zone have declined 5.5% at the surface and 18.6% in deep waters since 1980. Meanwhile, in a large subset of mostly nutrient-polluted lakes, surface oxygen levels increased as water temperatures crossed a threshold favoring cyanobacteria, which can create toxins when they flourish in the form of harmful algal blooms.
"All complex life depends on oxygen. It's the support system for aquatic food webs. And when you start losing oxygen, you have the potential ...
Chinese researchers realized an elementary link of a quantum repeater based on absorptive quantum memories (QMs) and demonstrated the multiplexed quantum repeater for the first time. On June 2nd?the work is published in Nature.
The fundamental task of a quantum network is to distribute quantum entanglement between two remote locations. However, the transmission loss of optical fiber has limited the distance of entanglement distribution to approximately 100 km on the ground. Quantum repeaters can overcome this difficulty by dividing long-distance transmission into several short-distance elementary links. The entanglement of two end nodes of each link is created firstly. Then the entanglement distance is gradually expanded through entanglement swapping between each link.
Previously, an ...
HOUSTON - (June 2, 2021) - It's official: Hexagonal boron nitride (h-BN) is the iron man of 2D materials, so resistant to cracking that it defies a century-old theoretical description engineers still use to measure toughness.
"What we observed in this material is remarkable," said Rice University's Jun Lou, co-corresponding author of a Nature paper published this week. "Nobody expected to see this in 2D materials. That's why it's so exciting."
Lou explains the significance of the discovery by comparing the fracture toughness of h-BN with that of its better-known cousin ...
The study, published in the journal Nature, shows how a drug available on the NHS can boost fitness of healthy stem cells in the gut, making them more resistant to sabotage from mutant stem cells that cause cancer.
Researchers in the Netherlands, funded by the UK charity Worldwide Cancer Research, have discovered a way to boost the fitness of healthy cells in the gut to prevent the development of bowel cancer. The findings have led to the initiation of a clinical trial to find out if a commonly used psychiatric drug could be used to prevent bowel cancer in people. The trial will recruit patients with a genetic mutation that means they are virtually 100% certain to develop bowel cancer in their lifetime, unless ...
Metastases can develop in the body even years after apparently successful cancer treatment. They originate from cancer cells that migrated from the original tumor to other organs, and which can lie there inactive for a considerable time. Researchers have now discovered how these "sleeping cells" are kept dormant and how they wake up and form fatal metastases. They have reported their findings in the journal Nature.
A tumor can leave behind an ominous legacy in the body: cancer cells can migrate from the tumor to other tissues in the body, where they survive after treatment in a kind of hibernation called dormancy. Currently, cancer medicine relies on monitoring cancer patients ...
Studies on cancer are limited by the threshold at which cellular transformations become clinically detectable. However, the very initial phase on the way to malignancy is histologically invisible, as the process originates from one single cell. In this early phase, a so-called "seeding cell" acquires an initial pro-cancerous mutation, also known as the "first oncogenic hit", while being completely surrounded by normal tissue. To overcome the detection barrier, a team of researchers around IMBA group leader Bon-Kyoung Koo and University of Cambridge group leader Professor Benjamin D. Simons developed a laboratory system to dissect the pre-cancerous steps that remained under the radar ...
A team of researchers led by the University of Cambridge and University of Utrecht examined trends in daily crime counts before and after COVID-19 restrictions were implemented in major metropolitan areas such as Barcelona, Chicago, Sao Paulo, Tel Aviv, Brisbane and London.
While both stringency of lockdowns and the resulting crime reductions varied considerably from city to city, the researchers found that most types of crime - with the key exception of homicide - fell significantly in the study sites.
Across all 27 cities, daily assaults fell ...
Clinical trials published in high-profile medical journals rarely report on income or other key sociodemographic characteristics of study participants, according to a new study that suggests these gaps may create blind spots when it comes to health care, especially for disadvantaged populations.
The study, publishing June 2 in JAMA Network Open, analyzed 10 per cent of 2,351 randomized clinical trials published in New England Journal of Medicine, JAMA, The BMJ, The Lancet and Annals of Internal Medicine between Jan. 1, 2014 and July 31, 2020.
The most commonly reported sociodemographic variables were sex and gender (in 98.7 per cent of trials) and race/ethnicity (in 48.5 per cent). All other sociodemographic ...
